Item:Q15050: Difference between revisions

Revision as of 17:45, 26 November 2023 Fire (talk \| contribs) Bureaucrats, Interface administrators, Administrators 132,454 edits ‎Added [en] aliases: (4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]valeric acid, (4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid, 3a-Hydroxy-5b-cholan-24-oic acid(3a,5b)-3-hydroxy-cholan-24-oate, 3a-Hydroxy-5b-cholan-24-oate, (4R)-4-[(1S,2S,5R,10R,11S,14R,15R)-5-hydroxy-2,15-d... ← Older edit	Latest revision as of 17:54, 26 November 2023 Fire (talk \| contribs) Bureaucrats, Interface administrators, Administrators 132,454 edits ‎Created claim: instance of (P2): type of chemical entity (Q2546)
	Property / instance of
		type of chemical entity
	Property / instance of: type of chemical entity / rank
		Normal rank